Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study

Pietro Geri, Francesco Salton, Lina Zuccatosta, Mario Tamburrini, Marco Biolo, Annalisa Busca, Mario Santagiuliana, Umberto Zuccon, Paola Confalonieri, Barbara Ruaro, Pierlanfranco D'Agaro, Stefano Gasparini, Marco Confalonieri
European Respiratory Journal 2020; DOI: 10.1183/13993003.01733-2020
Pietro Geri
1Pulmonology Unit, University Hospital of Trieste, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francesco Salton
1Pulmonology Unit, University Hospital of Trieste, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lina Zuccatosta
2Pulmonology and Bronchology Unit, Marche Polytechnic University Hospital, Ancona, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario Tamburrini
3Pulmonology Unit, General Hospital of Pordenone, Pordenone, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mario Tamburrini
Marco Biolo
1Pulmonology Unit, University Hospital of Trieste, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annalisa Busca
1Pulmonology Unit, University Hospital of Trieste, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mario Santagiuliana
1Pulmonology Unit, University Hospital of Trieste, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Umberto Zuccon
3Pulmonology Unit, General Hospital of Pordenone, Pordenone, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Paola Confalonieri
1Pulmonology Unit, University Hospital of Trieste, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Barbara Ruaro
1Pulmonology Unit, University Hospital of Trieste, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pierlanfranco D'Agaro
4Virology Lab, University of Trieste, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Gasparini
2Pulmonology and Bronchology Unit, Marche Polytechnic University Hospital, Ancona, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Confalonieri
1Pulmonology Unit, University Hospital of Trieste, Trieste, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Given the strong agreement between negative upper respiratory swabs and BAL, we suggest that BAL has a limited role in the diagnosis of Covid-19 if thoracic imaging and upper respiratory swabs are concordantly negative.

Manuscript

Despite an early and reliable recognition of Covid-19 is essential for disease control both at a community and hospital level, clinical picture and thoracic imaging alone are not sufficiently specific to distinguish it from other respiratory infections [1, 2]. Real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) is routinely used for qualitative and quantitative SARS-CoV-2 detection in specimens collected from the upper respiratory tract (URs) including nasal (Ns) or nasopharyngeal swabs (NPs), but a second-line investigation like bronchoalveolar lavage (BAL) is often required to diagnose or exclude SARS-CoV-2 infection in a clinical context of possible Covid-19. A significantly lower positive rate in nasopharyngeal swabs (32%) compared to BAL samples (93%) was recently reported [3]; however, BAL was collected in only 15 of 205 patients and in only one case BAL and nasopharyngeal swab were collected simultaneously.

We have retrospectively evaluated the agreement between negative URs and sequential BAL specimens in 79 consecutive inpatients admitted to respiratory units or respiratory high-dependency units of three Italian hub hospitals between March 14, 2020 and May 04, 2020 due to acute hypoxemic respiratory failure. In the three participating Centers, the number of positive PCRs on URs have been 7391 out of a total of 35708 URs tested.

BAL was performed in the Pulmonology Units of the University Hospital of Trieste, University Hospital of Ancona and Pordenone General Hospital after 24–48 h from at least one negative or indeterminate Ns or NPs, due to persistence of clinical suspect for Covid-19 as defined by: fever, hypoxemic respiratory failure, pulmonary infiltrates on chest X-ray or CT-scan and a recent contact with a confirmed case of Covid-19.

BAL was performed under local anesthesia and mild sedation, instillating repeated aliquotes of sterile saline into the most involved parenchymal area according to radiological findings. At least 50cc of lavage fluid were collected from each procedure. No patients experienced complications or worsening of the respiratory status after the procedure. All specimens were analysed using rRT-PCR in the virology lab of the respective hospital. A cycle threshold value higher than 40 was interpreted as negative. Each patient signed informed consents for both the endoscopic procedure and data collection.

Among the 79 patients, aged 65±17 years, 59 were males and 20 females. 50 patients had 2 (n=46) or 3 (n=4) consecutive negative URs; 2 had the first result reported as indeterminate, that is weak reactivity at the screening test (E and N gene search, according to CDC protocol) and a negative confirmation test (RdRp gene search), and 1 of them repeated the test with a negative result. Only 2 patients with negative swabs had significantly detectable levels of SARS-CoV-2 RNA in BAL samples, one with 2 negative NPs and the other with a first indeterminate result, giving a 97.5% overall agreement between URs and BAL analysis (moderate agreement, Cohen's k=0.487). An alternative etiologic agent was identified in 22 subjects and one patient had 3 negative URs and 1 indeterminate BAL result. In our population, 63 patients underwent elective chest CT, which revealed signs compatible with an ongoing viral infection in 38 cases. Normal CT scan were found in 10 cases with negative swabs and none of them had a positive BAL for SARS-CoV-2 (100% agreement).

Given the rapid spreading of Covid-19, diagnostic test accuracy has become of paramount importance in order to offer the best care to patients and to protect both community and medical staff. In our population, we have observed a high concordance between URs and BAL, which is currently considered the gold standard to detect pathogens in the presence of pulmonary infiltrates. We speculate that no concomitant pulmonary infections were detected in most cases mainly due to the fact that all patients had already started an empirical antibiotic treatment regimen 2±1 days in advance. False negative swabs have already been described in patients showing baseline thorax CT features compatible with viral pneumonia [4] and a recent consensus statement on chest CT findings related to Covid-19 defined three patterns of appearance: typical, indeterminate and atypical [5]. In our study, in the only 2 cases with a positive BAL test following negative and/or indeterminate URs, CT-scan showed a typical appearance for Covid-19: crazy paving pattern and peripheral bilateral ground glass opacities [6].

To our knowledge, this is the largest described BAL series in Covid-19. Given the strong agreement between negative URs and BAL and according to the recent American Association for Bronchology and Interventional Pulmonology statement [7], our findings support a limited role for BAL in the diagnosis of Covid-19 if thoracic imaging and URs are concordantly negative.

Although BAL might not add information to the diagnose of COVID-19, we highlight that it might be necessary in patients with a negative nasopharyngeal swab to establish a different diagnosis of either infectious or noninfectious nature.

Footnotes

  • Conflict of interest: Dr. Geri has nothing to disclose.

  • Conflict of interest: Dr. Salton has nothing to disclose.

  • Conflict of interest: Dr. Zuccatosta has nothing to disclose.

  • Conflict of interest: Dr. Tamburrini has nothing to disclose.

  • Conflict of interest: Dr. Biolo has nothing to disclose.

  • Conflict of interest: Dr. Busca has nothing to disclose.

  • Conflict of interest: Dr. Santagiuliana has nothing to disclose.

  • Conflict of interest: Dr. Zuccon has nothing to disclose.

  • Conflict of interest: Dr. Confalonieri has nothing to disclose.

  • Conflict of interest: Dr. Ruaro has nothing to disclose.

  • Conflict of interest: Dr. D'Agaro has nothing to disclose.

  • Conflict of interest: Dr. Gasparini has nothing to disclose.

  • Conflict of interest: Dr. Confalonieri has nothing to disclose.

  • Received May 11, 2020.
  • Accepted July 29, 2020.
  • Copyright ©ERS 2020
http://creativecommons.org/licenses/by-nc/4.0/

This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

References

  1. ↵
    1. Huang C,
    2. Wang Y,
    3. Li X, et al.
    Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497–506. doi:10.1016/S0140-6736(20)30183-5
    OpenUrlCrossRefPubMed
  2. ↵
    1. Zhou Z,
    2. Guo D,
    3. Li C, et al.
    Coronavirus disease 2019: initial chest CT findings. Eur Radiol 2020; 30: 4398–4406. doi:10.1007/s00330-020-06816-7
    OpenUrl
  3. ↵
    1. Wang W,
    2. Xu Y,
    3. Gao R, et al.
    Detection of SARS-CoV-2 in Different Types of Clinical Specimens. JAMA 2020; 323: 1843–1844.
    OpenUrlPubMed
  4. ↵
    1. Fang Y,
    2. Zhang H,
    3. Xie J, et al.
    Sensitivity of Chest CT for COVID-19: Comparison to RT-PCR. Radiology 2020; 296: E115–E117. doi:10.1148/radiol.2020200432
    OpenUrl
  5. ↵
    1. Simpson S,
    2. Kay FU,
    3. Abbara S, et al.
    Radiological Society of North America Expert Consensus Statement on Reporting Chest CT Findings Related to COVID-19. Endorsed by the Society of Thoracic Radiology, the American College of Radiology, and RSNA. Radiol Cardiothorac Imaging 2020; 2: e200152. [cited 2020 May 11] http://pubs.rsna.org/doi/10.1148/ryct.2020200152 doi:10.1148/ryct.2020200152
    OpenUrl
  6. ↵
    1. Chung M,
    2. Bernheim A,
    3. Mei X, et al.
    CT imaging features of 2019 novel coronavirus (2019-NCoV). Radiology 2020; 295: 202–207. doi:10.1148/radiol.2020200230
    OpenUrlCrossRefPubMed
  7. ↵
    1. Wahidi MM,
    2. Lamb C,
    3. Murgu S, et al.
    American Association for Bronchology and Interventional Pulmonology (AABIP) Statement on the Use of Bronchoscopy and Respiratory Specimen Collection in Patients with Suspected or Confirmed COVID-19 Infection. J Bronchology Interv Pulmonol 2020.
PreviousNext
Back to top
View this article with LENS
Vol 60 Issue 2 Table of Contents
European Respiratory Journal: 60 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study
Pietro Geri, Francesco Salton, Lina Zuccatosta, Mario Tamburrini, Marco Biolo, Annalisa Busca, Mario Santagiuliana, Umberto Zuccon, Paola Confalonieri, Barbara Ruaro, Pierlanfranco D'Agaro, Stefano Gasparini, Marco Confalonieri
European Respiratory Journal Jan 2020, 2001733; DOI: 10.1183/13993003.01733-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Limited role for bronchoalveolar lavage to exclude Covid-19 after negative upper respiratory tract swabs: a multicenter study
Pietro Geri, Francesco Salton, Lina Zuccatosta, Mario Tamburrini, Marco Biolo, Annalisa Busca, Mario Santagiuliana, Umberto Zuccon, Paola Confalonieri, Barbara Ruaro, Pierlanfranco D'Agaro, Stefano Gasparini, Marco Confalonieri
European Respiratory Journal Jan 2020, 2001733; DOI: 10.1183/13993003.01733-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Manuscript
    • Footnotes
    • References
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Right ventricular-pulmonary arterial coupling and its relationship to exercise haemodynamics in a continuum of patients with pulmonary vascular disease due to chronic thromboembolism
  • Evaluation of the Global Lung Initiative 2012 Reference Values for Spirometry in China: A national cross-sectional study
  • Improved ventilatory efficiency to evidence haemodynamic improvement after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
Show more Research letter

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society